These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25724189)

  • 1. A Multiplexed Cell-Based Assay for the Identification of Modulators of Pre-Membrane Processing as a Target against Dengue Virus.
    Stolp ZD; Smurthwaite CA; Reed C; Williams W; Dharmawan A; Djaballah H; Wolkowicz R
    J Biomol Screen; 2015 Jun; 20(5):616-26. PubMed ID: 25724189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-content assay to identify inhibitors of dengue virus infection.
    Shum D; Smith JL; Hirsch AJ; Bhinder B; Radu C; Stein DA; Nelson JA; Früh K; Djaballah H
    Assay Drug Dev Technol; 2010 Oct; 8(5):553-70. PubMed ID: 20973722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based antiviral assays for screening and profiling inhibitors against dengue virus.
    Gong EY; Clynhens M; Ivens T; Lory P; Simmen K; Kraus G
    Methods Mol Biol; 2013; 1030():185-94. PubMed ID: 23821269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M; Singh SK
    Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
    Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
    Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M; Liu W; Yuan Z; Gu F; Shi PY
    Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional importance of dengue virus maturation: infectious properties of immature virions.
    Zybert IA; van der Ende-Metselaar H; Wilschut J; Smit JM
    J Gen Virol; 2008 Dec; 89(Pt 12):3047-3051. PubMed ID: 19008392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry.
    Hsieh SC; Wu YC; Zou G; Nerurkar VR; Shi PY; Wang WK
    J Biol Chem; 2014 Nov; 289(48):33149-60. PubMed ID: 25326389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus.
    Mohan S; McAtamney S; Jayakanthan K; Eskandari R; von Itzstein M; Pinto BM
    Int J Antimicrob Agents; 2012 Sep; 40(3):273-6. PubMed ID: 22784856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for development of Dengue virus inhibitors.
    Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
    Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
    Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
    Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit.
    Kounde CS; Yeo HQ; Wang QY; Wan KF; Dong H; Karuna R; Dix I; Wagner T; Zou B; Simon O; Bonamy GMC; Yeung BKS; Yokokawa F
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1385-1389. PubMed ID: 28216045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.